- Home
- ALLE vs MEDP Comparison
ALLE vs MEDP Comparison
Compare ALLE & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLE
- MEDP
- Stock Information
- Founded
- ALLE 2013
- MEDP 1992
- Country
- ALLE Ireland
- MEDP United States
- Employees
- ALLE N/A
- MEDP N/A
- Industry
- ALLE Diversified Commercial Services
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ALLE Consumer Discretionary
- MEDP Health Care
- Exchange
- ALLE Nasdaq
- MEDP Nasdaq
- Market Cap
- ALLE 10.9B
- MEDP 10.5B
- IPO Year
- ALLE N/A
- MEDP 2016
- Fundamental
- Price
- ALLE $127.17
- MEDP $340.22
- Analyst Decision
- ALLE Hold
- MEDP Buy
- Analyst Count
- ALLE 6
- MEDP 10
- Target Price
- ALLE $138.33
- MEDP $389.89
- AVG Volume (30 Days)
- ALLE 985.2K
- MEDP 310.8K
- Earning Date
- ALLE 02-18-2025
- MEDP 02-10-2025
- Dividend Yield
- ALLE 1.61%
- MEDP N/A
- EPS Growth
- ALLE 11.44
- MEDP 42.23
- EPS
- ALLE 6.82
- MEDP 12.63
- Revenue
- ALLE $3,772,200,000.00
- MEDP $2,109,054,000.00
- Revenue This Year
- ALLE $5.24
- MEDP $7.54
- Revenue Next Year
- ALLE $3.67
- MEDP $11.55
- P/E Ratio
- ALLE $18.55
- MEDP $27.15
- Revenue Growth
- ALLE 3.33
- MEDP 11.84
- 52 Week Low
- ALLE $113.27
- MEDP $302.01
- 52 Week High
- ALLE $156.10
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- ALLE 41.23
- MEDP 47.17
- Support Level
- ALLE $124.19
- MEDP $336.78
- Resistance Level
- ALLE $134.25
- MEDP $347.58
- Average True Range (ATR)
- ALLE 2.43
- MEDP 12.05
- MACD
- ALLE -0.33
- MEDP -0.79
- Stochastic Oscillator
- ALLE 29.60
- MEDP 34.48
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2023, Allegion generated 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy and Switzerland-based Dormakaba.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.